Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study.

Saved in:
Bibliographic Details
Title: Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study.
Authors: Wang M; Phase I Clinical Trial Centre, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, 430030, Hubei Province, China., Peng Y; Phase I Clinical Trial Centre, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, 430030, Hubei Province, China., Yan H; Phase I Clinical Trial Centre, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, 430030, Hubei Province, China., Pan Z; Phase I Clinical Trial Centre, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, 430030, Hubei Province, China., Du R; Phase I Clinical Trial Centre, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, 430030, Hubei Province, China. 2782044387@qq.com., Liu G; Phase I Clinical Trial Centre, Wuhan Pulmonary Hospital, Wuhan Institute of Tuberculosis Prevention and Control, Wuhan, 430030, Hubei Province, China. liuguantbdoctor@hotmail.com.
Source: Drugs in R&D [Drugs R D] 2025 Jun; Vol. 25 (2), pp. 117-125. Date of Electronic Publication: 2025 Apr 26.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-6901 (Electronic) Linking ISSN: 11745886 NLM ISO Abbreviation: Drugs R D Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-6901
DOI:10.1007/s40268-025-00508-7